Pharmafile Logo
Pharmafocus logo
Advanced Search

Femara heralded as breakthrough in breast cancer

October 28, 2003
Sales and Marketing

Compelling new evidence showing Novartis' Femara reduces the risk of breast cancer recurring in patients has been heralded as a …

News

Risk-sharing agreement failing MS patients

October 28, 2003
Sales and Marketing

News

FDA clears Iressa of safety concerns

October 28, 2003
Sales and Marketing

AstraZeneca's lung cancer drug Iressa has gained US approval after an extended review found the drug to be safe, despite …

News

GSK to remove Seroxat ‘not addictive’ claim

October 28, 2003
Sales and Marketing

GlaxoSmithKline is to drop claims on patient information leaflets that its antidepressant Seroxat is not addictive.The admission is to be …

News

AZ promise despite Losec drop

October 28, 2003
Sales and Marketing

News

Blair and Milburn braced for foundation trust backlash

October 28, 2003
NHS

 The Government’s controversial plans to introduce foundation hospitals are on a knife-edge ahead of a Commons vote on the reform …

News

PowderJect rises on takeover bid

October 28, 2003
Research and Development

News

GSK prospers despite generic competition

October 28, 2003
Sales and Marketing

News

OTC omeprazole to become Glaxo’s next generation Zantac

October 28, 2003
Sales and Marketing

GlaxoSmithKline is poised to launch omeprazole, AstraZeneca's former prescription-only blockbuster Losec as part of its leading over the counter Zantac …

News

Vernalis seeks funding and takeover offers

October 28, 2003
Research and Development

News

Sanofi upgrades expectations for 2003

October 28, 2003
Sales and Marketing

Sanofi-Synthelabo has upgraded its full-year share earnings guidance for 2003, despite its plans to spend more on R&D.In the first …

News

Concerns over expansion of fast track surgery

October 28, 2003

Doctors and health unions have expressed their concerns about the effect of new fast track surgery centres on the rest …

News

GlaxoSmithKline slashes AIDS drug prices

October 28, 2003
Sales and Marketing

GlaxoSmithKline has cut prices of its HIV/AIDS drugs for developing countries by nearly half following intense pressure from campaigners and …

News

International performance keeps BMS afloat

October 28, 2003
Sales and Marketing

International sales of several key drugs helped Bristol-Myers Squibb to minimise the effects of continued US generic competition in the …

News

GPs ‘in favour’ of charging patients

October 28, 2003

News

Government proposes ‘clinical exceptions’ to A&E targets

October 28, 2003

The Government is to modify one of its key waiting times targets after sustained protests about its inability to reflect …

News

UK invests in cancer research programme

October 28, 2003

News

AstraZeneca claims Symbicort superior to Seretide

October 28, 2003

News

Money Syner buy-out to create UK’s biggest healthcare agency

October 28, 2003

Global healthcare communications agency Euro RSCG Life has acquired Money Syner Communications to create what it says will be the …

News

Pfizer spots potential of Organon atypical antipsychotic

October 28, 2003

Pfizer is  to co-develop and promote a promising new atypical antipsychotic discovered by Dutch pharma company Organon.Under the terms of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025